TOWARDS QUALITY-ASSURED, PATIENT-CENTRIC, PROACTIVE AND SUSTAINABLE PHARMACOVIGILANCE IN THE REAL WORLD
With major product recalls in recent years – including the suspension of 700 products earlier this year due to fake clinical trials, regulatory authorities across Asia are tightening regulations to safeguard consumer health. Hence, it is vital that pharmacovigilance professionals process these safety reports in an accurate and timely manner, while negotiating the diverse and often ambiguous regulatory requirements across the region.
6th Annual Pharmacovigilance Asia 2015 takes a look at creating a more pro-active and quality-assured pharmacovigilance system in Asia, as well as building sustainability and capability in Asia.
Join our regional and global thought leaders from top firms as they share real-life examples, case studies and best practice on how to re-evaluate and optimize their processes and people throughout the product’s life cycle.
“Simple enough for a beginner, complex enough for the experienced. Brilliant!” - Senior Safety Officer, GSK
“Very well organised conference. Attendee mix was nice – including industry and regulators! Well done!”- Pharmacovigilance Head, Cipla
“This conference offers the opportunity for those working in pharmacovigilance to share expertise and learn about best practices and challenge the way they do things.”- Pharmacovigilance manager, MSD
“Had an overall understanding of pharmacovigilance running in Asia, particularly in ASEAN. It is helpful for me to make a plan locally and accelerate pharmacovigilance strategy locally.”- Director of Regulatory Affairs, Nycomed China
“The IQPC Pharmacovigilance conference in Singapore, which is becoming an annual event is, to my knowledge, the most comprehensive information exchange and discussion forum dedicated to pharmacovigilance held in Asia so far.”- Head of Pharmacovigilance Asia-Pacific, Bayer Healthcare Global R&D Centre